A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer
Clinical trial NCT03042702 · COMPLETED
Trial details
- NCT number
- NCT03042702
- Sponsor
- Innovation Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-09
- Primary completion
- 2017-11-10
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.